Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine


We have previously reported the results of mizoribine (MZR) treatment for elderly patients with membranous nephropathy (MN). Here, we retrospectively compared these patients with those who had been initially treated with prednisolone (PSL) alone. The subjects were patients with MN aged ≥65 years who were examined between April 2007 and September 2010 and… (More)
DOI: 10.1007/s11255-014-0850-7

4 Figures and Tables


  • Presentations referencing similar topics